Romark Laboratories L.C.
Romark Global Pharma is a pharmaceutical company that develops and distributes pharmaceutical drugs. Romark is a pharmaceutical company committed to the discovery, development and commercialization of innovative small molecules for treating infectious diseases and cancers. The company's people share a passion for scientific discovery and a desire to make a difference in the world's health. Throughout all phases of drug discovery and development, we are teamed in a quest to provide new treatments for diseases that impact the lives of people worldwide.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
NT-300 (nitazoxanide extended-release tablets)
An oral antiviral drug candidate designed to treat and prevent acute respiratory illnesses caused by various respiratory viruses, including COVID-19.
Host-Directed Antiviral Therapeutics for COVID-19 and Respiratory Viral Infections
Therapeutic agents developed to treat COVID-19 and other viral respiratory infections by targeting host cellular mechanisms rather than the virus directly.
Therapeutics for Chronic Hepatitis B
Medications aimed at achieving functional cure of chronic hepatitis B by suppressing viral DNA and antigens using host-directed antiviral strategies.
Small Molecule Thiazolides for Various Therapeutic Areas
A class of small molecule drugs under development targeting viral diseases, cancers, nerve pain, neurodegenerative, and aging-related diseases.
NT-300 (nitazoxanide extended-release tablets)
An oral antiviral drug candidate designed to treat and prevent acute respiratory illnesses caused by various respiratory viruses, including COVID-19.
Host-Directed Antiviral Therapeutics for COVID-19 and Respiratory Viral Infections
Therapeutic agents developed to treat COVID-19 and other viral respiratory infections by targeting host cellular mechanisms rather than the virus directly.
Therapeutics for Chronic Hepatitis B
Medications aimed at achieving functional cure of chronic hepatitis B by suppressing viral DNA and antigens using host-directed antiviral strategies.
Small Molecule Thiazolides for Various Therapeutic Areas
A class of small molecule drugs under development targeting viral diseases, cancers, nerve pain, neurodegenerative, and aging-related diseases.